instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Pleural effusion'? | Sertraline as a rare cause of interstitial lung disease.
Sertraline, a selective serotonin reuptake inhibitor, is commonly prescribed for the treatment of moderate-to-severe depression. We report a case of a 36-year-old male taking sertraline for 7 weeks prior to developing a dry cough, pleuritic chest pain, hypoxia an... | Recovered | ReactionOutcome | CC BY-NC | 33948187 | 20,732,382 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Case Report-Staged brachytherapy achieving complete metabolic response in unresectable oligometastatic colorectal cancer to the liver.
Liver is the most common site for metastasis from colorectal cancer (CRC). Non-surgical treatment options for oligometastatic CRC confined to the liver which represents an intermediate ... | FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33948189 | 20,850,379 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Case Report-Staged brachytherapy achieving complete metabolic response in unresectable oligometastatic colorectal cancer to the liver.
Liver is the most common site for metastasis from colorectal cancer (CRC). Non-surgical treatment options for oligometastatic CRC confined to the liver which represents an intermediate ... | FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33948189 | 20,850,379 | 2021-04 |
What was the dosage of drug 'FLUOROURACIL'? | Case Report-Staged brachytherapy achieving complete metabolic response in unresectable oligometastatic colorectal cancer to the liver.
Liver is the most common site for metastasis from colorectal cancer (CRC). Non-surgical treatment options for oligometastatic CRC confined to the liver which represents an intermediate ... | 4 CYCLES OF SYSTEMIC FOLFOX REGIMEN | DrugDosageText | CC BY | 33948189 | 20,850,379 | 2021-04 |
What was the dosage of drug 'LEUCOVORIN CALCIUM'? | Case Report-Staged brachytherapy achieving complete metabolic response in unresectable oligometastatic colorectal cancer to the liver.
Liver is the most common site for metastasis from colorectal cancer (CRC). Non-surgical treatment options for oligometastatic CRC confined to the liver which represents an intermediate ... | 4 CYCLES OF SYSTEMIC FOLFOX REGIMEN?FOLINIC ACID | DrugDosageText | CC BY | 33948189 | 20,850,379 | 2021-04 |
What was the dosage of drug 'OXALIPLATIN'? | Case Report-Staged brachytherapy achieving complete metabolic response in unresectable oligometastatic colorectal cancer to the liver.
Liver is the most common site for metastasis from colorectal cancer (CRC). Non-surgical treatment options for oligometastatic CRC confined to the liver which represents an intermediate ... | 4 CYCLES OF SYSTEMIC FOLFOX REGIMEN | DrugDosageText | CC BY | 33948189 | 20,850,379 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiotoxicity'. | Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.
Conventional osteosarcoma is an orphan disease. Current treatment approaches include combining a three drug chemotherapy schedule and surgery. The 3- and 5-year event-free su... | DOXORUBICIN HYDROCHLORIDE, MIFAMURTIDE | DrugsGivenReaction | CC BY-NC-ND | 33948428 | 19,220,715 | 2021-06 |
What was the administration route of drug 'MIFAMURTIDE'? | Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.
Conventional osteosarcoma is an orphan disease. Current treatment approaches include combining a three drug chemotherapy schedule and surgery. The 3- and 5-year event-free su... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33948428 | 19,220,715 | 2021-06 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.
Conventional osteosarcoma is an orphan disease. Current treatment approaches include combining a three drug chemotherapy schedule and surgery. The 3- and 5-year event-free su... | UNK, CYCLIC | DrugDosageText | CC BY-NC-ND | 33948428 | 19,220,715 | 2021-06 |
What was the dosage of drug 'MIFAMURTIDE'? | Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.
Conventional osteosarcoma is an orphan disease. Current treatment approaches include combining a three drug chemotherapy schedule and surgery. The 3- and 5-year event-free su... | 2 MG/M2, CYCLIC (1?HOUR INFUSION) | DrugDosageText | CC BY-NC-ND | 33948428 | 19,220,715 | 2021-06 |
What was the outcome of reaction 'Cardiotoxicity'? | Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.
Conventional osteosarcoma is an orphan disease. Current treatment approaches include combining a three drug chemotherapy schedule and surgery. The 3- and 5-year event-free su... | Fatal | ReactionOutcome | CC BY-NC-ND | 33948428 | 19,220,715 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Confusional state'. | Thyroid Eye Disease: Navigating the New Treatment Landscape.
Thyroid eye disease (TED) is a complex inflammatory disease that can have a long clinical course with sight-threatening and debilitating ocular sequelae. Until recently, there were limited therapeutic options available. In the last decade we have gained a dee... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33948524 | 20,025,700 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Thyroid Eye Disease: Navigating the New Treatment Landscape.
Thyroid eye disease (TED) is a complex inflammatory disease that can have a long clinical course with sight-threatening and debilitating ocular sequelae. Until recently, there were limited therapeutic options available. In the last decade we have gained a dee... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33948524 | 20,025,700 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Insomnia'. | Thyroid Eye Disease: Navigating the New Treatment Landscape.
Thyroid eye disease (TED) is a complex inflammatory disease that can have a long clinical course with sight-threatening and debilitating ocular sequelae. Until recently, there were limited therapeutic options available. In the last decade we have gained a dee... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33948524 | 20,025,700 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Thyroid Eye Disease: Navigating the New Treatment Landscape.
Thyroid eye disease (TED) is a complex inflammatory disease that can have a long clinical course with sight-threatening and debilitating ocular sequelae. Until recently, there were limited therapeutic options available. In the last decade we have gained a dee... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33948524 | 20,025,700 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tremor'. | Thyroid Eye Disease: Navigating the New Treatment Landscape.
Thyroid eye disease (TED) is a complex inflammatory disease that can have a long clinical course with sight-threatening and debilitating ocular sequelae. Until recently, there were limited therapeutic options available. In the last decade we have gained a dee... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33948524 | 20,025,700 | 2021-05-01 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Thyroid Eye Disease: Navigating the New Treatment Landscape.
Thyroid eye disease (TED) is a complex inflammatory disease that can have a long clinical course with sight-threatening and debilitating ocular sequelae. Until recently, there were limited therapeutic options available. In the last decade we have gained a dee... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33948524 | 20,025,700 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram abnormal'. | Lacosamide induced Brugada I morphology in the setting of septicemia: A case report.
BACKGROUND
Brugada syndrome may be unmasked by non-antiarrhythmic pharmaceuticals or drugs. Lacosamide is an antiepileptic agent with a novel mechanism of sodium channel inhibition and has the potential to cause cardiac sodium channel ... | LACOSAMIDE, LEVETIRACETAM | DrugsGivenReaction | CC BY | 33950934 | 19,298,443 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Lacosamide induced Brugada I morphology in the setting of septicemia: A case report.
BACKGROUND
Brugada syndrome may be unmasked by non-antiarrhythmic pharmaceuticals or drugs. Lacosamide is an antiepileptic agent with a novel mechanism of sodium channel inhibition and has the potential to cause cardiac sodium channel ... | LACOSAMIDE, LEVETIRACETAM | DrugsGivenReaction | CC BY | 33950934 | 19,298,443 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Lacosamide induced Brugada I morphology in the setting of septicemia: A case report.
BACKGROUND
Brugada syndrome may be unmasked by non-antiarrhythmic pharmaceuticals or drugs. Lacosamide is an antiepileptic agent with a novel mechanism of sodium channel inhibition and has the potential to cause cardiac sodium channel ... | LACOSAMIDE, LEVETIRACETAM | DrugsGivenReaction | CC BY | 33950934 | 19,298,443 | 2021-05-07 |
What was the outcome of reaction 'Electrocardiogram abnormal'? | Lacosamide induced Brugada I morphology in the setting of septicemia: A case report.
BACKGROUND
Brugada syndrome may be unmasked by non-antiarrhythmic pharmaceuticals or drugs. Lacosamide is an antiepileptic agent with a novel mechanism of sodium channel inhibition and has the potential to cause cardiac sodium channel ... | Recovered | ReactionOutcome | CC BY | 33950934 | 19,298,443 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Staphylococcal infection'. | A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone.
BACKGROUND
Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation.
The pati... | MYCOPHENOLATE MOFETIL, PREDNISOLONE, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY | 33950951 | 19,511,751 | 2021-05-07 |
What was the administration route of drug 'DEXAMETHASONE'? | A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone.
BACKGROUND
Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation.
The pati... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33950951 | 19,520,629 | 2021-05-07 |
What was the administration route of drug 'REMDESIVIR'? | A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone.
BACKGROUND
Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation.
The pati... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33950951 | 19,595,129 | 2021-05-07 |
What was the outcome of reaction 'COVID-19 pneumonia'? | A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone.
BACKGROUND
Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation.
The pati... | Recovered | ReactionOutcome | CC BY | 33950951 | 19,595,129 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
BACKGROUND
Chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) have been used in the treatment of relapsed and refractory multiple myeloma (RRMM). The r... | BORTEZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY | 33950974 | 19,271,249 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
BACKGROUND
Chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) have been used in the treatment of relapsed and refractory multiple myeloma (RRMM). The r... | BORTEZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY | 33950974 | 19,271,249 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gait inability'. | Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
BACKGROUND
Chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) have been used in the treatment of relapsed and refractory multiple myeloma (RRMM). The r... | BORTEZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY | 33950974 | 19,271,249 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoaesthesia'. | Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
BACKGROUND
Chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) have been used in the treatment of relapsed and refractory multiple myeloma (RRMM). The r... | BORTEZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY | 33950974 | 19,271,249 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nerve injury'. | Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
BACKGROUND
Chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) have been used in the treatment of relapsed and refractory multiple myeloma (RRMM). The r... | BORTEZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY | 33950974 | 19,271,249 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic response decreased'. | Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
BACKGROUND
Chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) have been used in the treatment of relapsed and refractory multiple myeloma (RRMM). The r... | BORTEZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY | 33950974 | 19,271,249 | 2021-05-07 |
What was the outcome of reaction 'Diarrhoea'? | Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
BACKGROUND
Chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) have been used in the treatment of relapsed and refractory multiple myeloma (RRMM). The r... | Recovering | ReactionOutcome | CC BY | 33950974 | 19,271,249 | 2021-05-07 |
What was the outcome of reaction 'Fatigue'? | Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
BACKGROUND
Chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) have been used in the treatment of relapsed and refractory multiple myeloma (RRMM). The r... | Recovering | ReactionOutcome | CC BY | 33950974 | 19,271,249 | 2021-05-07 |
What was the outcome of reaction 'Hypoaesthesia'? | Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
BACKGROUND
Chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) have been used in the treatment of relapsed and refractory multiple myeloma (RRMM). The r... | Recovering | ReactionOutcome | CC BY | 33950974 | 19,271,249 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrophy'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Focal segmental glomerulosclerosis'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Generalised oedema'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematuria'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperplasia'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Kidney fibrosis'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhonchi'. | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the dosage of drug 'CISPLATIN'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | UNK UNK, QCY | DrugDosageText | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the dosage of drug 'DOCETAXEL'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | UNK UNK, QCY | DrugDosageText | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Atrophy'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Focal segmental glomerulosclerosis'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Generalised oedema'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Haematuria'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Hyperplasia'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Kidney fibrosis'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Oedema peripheral'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Proteinuria'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Renal impairment'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
What was the outcome of reaction 'Rhonchi'? | Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
BACKGROUND
Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases, leading to end-stage renal disease. Among the 5 variants of FSGS, the collapsing variant is rare and has the worst progno... | Recovered | ReactionOutcome | CC BY | 33951000 | 19,292,920 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aphasia'. | Three Cases of Aphasic Status Epilepticus: Clinical and Electrographic Characteristics.
Aphasic status epilepticus (ASE) is unusual and has clinical characteristics similar to those of other disorders. Herein, we report 3 cases of ASE. A left-handed man (patient 1) showed continuous aphasia after the administration of ... | FLURAZEPAM HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33953631 | 19,277,921 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Confusional state'. | Three Cases of Aphasic Status Epilepticus: Clinical and Electrographic Characteristics.
Aphasic status epilepticus (ASE) is unusual and has clinical characteristics similar to those of other disorders. Herein, we report 3 cases of ASE. A left-handed man (patient 1) showed continuous aphasia after the administration of ... | FLURAZEPAM HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33953631 | 19,277,921 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Three Cases of Aphasic Status Epilepticus: Clinical and Electrographic Characteristics.
Aphasic status epilepticus (ASE) is unusual and has clinical characteristics similar to those of other disorders. Herein, we report 3 cases of ASE. A left-handed man (patient 1) showed continuous aphasia after the administration of ... | FLURAZEPAM HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33953631 | 19,277,921 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Three Cases of Aphasic Status Epilepticus: Clinical and Electrographic Characteristics.
Aphasic status epilepticus (ASE) is unusual and has clinical characteristics similar to those of other disorders. Herein, we report 3 cases of ASE. A left-handed man (patient 1) showed continuous aphasia after the administration of ... | FLURAZEPAM HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33953631 | 19,277,921 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Three Cases of Aphasic Status Epilepticus: Clinical and Electrographic Characteristics.
Aphasic status epilepticus (ASE) is unusual and has clinical characteristics similar to those of other disorders. Herein, we report 3 cases of ASE. A left-handed man (patient 1) showed continuous aphasia after the administration of ... | FLURAZEPAM HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33953631 | 19,277,921 | 2021 |
What was the dosage of drug 'FLURAZEPAM HYDROCHLORIDE'? | Three Cases of Aphasic Status Epilepticus: Clinical and Electrographic Characteristics.
Aphasic status epilepticus (ASE) is unusual and has clinical characteristics similar to those of other disorders. Herein, we report 3 cases of ASE. A left-handed man (patient 1) showed continuous aphasia after the administration of ... | 15 MG | DrugDosageText | CC BY-NC | 33953631 | 19,277,921 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Aseptic Meningitis after Recovery from SARS-CoV-2 in an Allogeneic Stem Cell Transplant Recipient.
SARS-CoV-2 emerged as a worldwide pandemic in late 2019 and initially was described as a primary respiratory illness. The clinical manifestations of COVID-19 are now known to encompass nearly all organ systems, including ... | LEVETIRACETAM, METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33953633 | 20,499,998 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins.
Autoimmune polyendocrine syndromes (APS) are a heterogeneous group of diseases characterized by the presence of autoimmune dysfunction of 2 or more endocrine glands and other non-endocrine organs. The components of the syndro... | FLUDROCORTISONE, HYDROCORTISONE | DrugsGivenReaction | CC BY-NC | 33953634 | 20,012,916 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins.
Autoimmune polyendocrine syndromes (APS) are a heterogeneous group of diseases characterized by the presence of autoimmune dysfunction of 2 or more endocrine glands and other non-endocrine organs. The components of the syndro... | FLUDROCORTISONE, HYDROCORTISONE | DrugsGivenReaction | CC BY-NC | 33953634 | 20,012,916 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight increased'. | Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins.
Autoimmune polyendocrine syndromes (APS) are a heterogeneous group of diseases characterized by the presence of autoimmune dysfunction of 2 or more endocrine glands and other non-endocrine organs. The components of the syndro... | FLUDROCORTISONE, HYDROCORTISONE | DrugsGivenReaction | CC BY-NC | 33953634 | 20,012,916 | 2021 |
What was the dosage of drug 'FLUDROCORTISONE'? | Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins.
Autoimmune polyendocrine syndromes (APS) are a heterogeneous group of diseases characterized by the presence of autoimmune dysfunction of 2 or more endocrine glands and other non-endocrine organs. The components of the syndro... | PER DAY | DrugDosageText | CC BY-NC | 33953634 | 20,012,916 | 2021 |
What was the dosage of drug 'HYDROCORTISONE'? | Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins.
Autoimmune polyendocrine syndromes (APS) are a heterogeneous group of diseases characterized by the presence of autoimmune dysfunction of 2 or more endocrine glands and other non-endocrine organs. The components of the syndro... | PER DAY | DrugDosageText | CC BY-NC | 33953634 | 20,012,916 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Adrenal and Hepatic Venous Sampling in a Case of Aldosterone-Producing Adrenocortical Carcinoma with Hepatic Metastasis.
Adrenocortical carcinoma (ACC) is a rare and highly aggressive malignancy. ACCs often secrete adrenal steroid hormones including cortisol and androgens; however, aldosterone-producing ACC is very rar... | SPIRONOLACTONE | DrugsGivenReaction | CC BY | 33953990 | 19,623,275 | 2021 |
What was the dosage of drug 'SPIRONOLACTONE'? | Adrenal and Hepatic Venous Sampling in a Case of Aldosterone-Producing Adrenocortical Carcinoma with Hepatic Metastasis.
Adrenocortical carcinoma (ACC) is a rare and highly aggressive malignancy. ACCs often secrete adrenal steroid hormones including cortisol and androgens; however, aldosterone-producing ACC is very rar... | UNK/ HIGH DOSE | DrugDosageText | CC BY | 33953990 | 19,623,275 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | Adrenal and Hepatic Venous Sampling in a Case of Aldosterone-Producing Adrenocortical Carcinoma with Hepatic Metastasis.
Adrenocortical carcinoma (ACC) is a rare and highly aggressive malignancy. ACCs often secrete adrenal steroid hormones including cortisol and androgens; however, aldosterone-producing ACC is very rar... | Fatal | ReactionOutcome | CC BY | 33953990 | 19,623,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Symptom masked'. | Pheochromocytoma Presenting as Testicular Pain: An Unusual Case Report.
Pheochromocytoma (PCC) is a rare catecholamine-secreting tumor that arises from chromaffin cells of the adrenal medulla which are derived from the neural crest. This report illustrates a 51-year-old Caucasian male with a history of hypertension dia... | LISINOPRIL | DrugsGivenReaction | CC BY | 33953991 | 19,480,653 | 2021 |
What was the administration route of drug 'LISINOPRIL'? | Pheochromocytoma Presenting as Testicular Pain: An Unusual Case Report.
Pheochromocytoma (PCC) is a rare catecholamine-secreting tumor that arises from chromaffin cells of the adrenal medulla which are derived from the neural crest. This report illustrates a 51-year-old Caucasian male with a history of hypertension dia... | Oral | DrugAdministrationRoute | CC BY | 33953991 | 19,480,653 | 2021 |
What was the outcome of reaction 'Symptom masked'? | Pheochromocytoma Presenting as Testicular Pain: An Unusual Case Report.
Pheochromocytoma (PCC) is a rare catecholamine-secreting tumor that arises from chromaffin cells of the adrenal medulla which are derived from the neural crest. This report illustrates a 51-year-old Caucasian male with a history of hypertension dia... | Recovered | ReactionOutcome | CC BY | 33953991 | 19,480,653 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Langerhans cell histiocytosis (LCH) is an infrequent disease, characterized by oligoclonal proliferation of immature myeloid-derived cells. However, the exact pathogenesis remains unknown. In rare cases, LCH is pr... | CLOPIDOGREL BISULFATE, CYTARABINE, MECHLORETHAMINE HYDROCHLORIDE, SIMVASTATIN, TAMSULOSIN, VEMURAFENIB | DrugsGivenReaction | CC BY | 33953993 | 19,457,110 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Langerhans cell histiocytosis (LCH) is an infrequent disease, characterized by oligoclonal proliferation of immature myeloid-derived cells. However, the exact pathogenesis remains unknown. In rare cases, LCH is pr... | CLOPIDOGREL BISULFATE, CYTARABINE, MECHLORETHAMINE HYDROCHLORIDE, SIMVASTATIN, TAMSULOSIN, VEMURAFENIB | DrugsGivenReaction | CC BY | 33953993 | 19,457,110 | 2021 |
What was the administration route of drug 'CYTARABINE'? | Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Langerhans cell histiocytosis (LCH) is an infrequent disease, characterized by oligoclonal proliferation of immature myeloid-derived cells. However, the exact pathogenesis remains unknown. In rare cases, LCH is pr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33953993 | 19,457,110 | 2021 |
What was the administration route of drug 'MECHLORETHAMINE HYDROCHLORIDE'? | Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Langerhans cell histiocytosis (LCH) is an infrequent disease, characterized by oligoclonal proliferation of immature myeloid-derived cells. However, the exact pathogenesis remains unknown. In rare cases, LCH is pr... | Topical | DrugAdministrationRoute | CC BY | 33953993 | 19,457,110 | 2021 |
What was the administration route of drug 'VEMURAFENIB'? | Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Langerhans cell histiocytosis (LCH) is an infrequent disease, characterized by oligoclonal proliferation of immature myeloid-derived cells. However, the exact pathogenesis remains unknown. In rare cases, LCH is pr... | Oral | DrugAdministrationRoute | CC BY | 33953993 | 19,457,110 | 2021 |
What was the outcome of reaction 'Acute myocardial infarction'? | Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Langerhans cell histiocytosis (LCH) is an infrequent disease, characterized by oligoclonal proliferation of immature myeloid-derived cells. However, the exact pathogenesis remains unknown. In rare cases, LCH is pr... | Fatal | ReactionOutcome | CC BY | 33953993 | 19,457,110 | 2021 |
What was the outcome of reaction 'Infection'? | Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Langerhans cell histiocytosis (LCH) is an infrequent disease, characterized by oligoclonal proliferation of immature myeloid-derived cells. However, the exact pathogenesis remains unknown. In rare cases, LCH is pr... | Fatal | ReactionOutcome | CC BY | 33953993 | 19,457,110 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epistaxis'. | Medical students as junior adverse drug event managers facilitating reporting of ADRs.
The Junior Adverse Drug Event Manager (J-ADEM) team is a multifaceted intervention focusing on real-life education for medical students that has been shown to assist healthcare professionals in managing and reporting suspected advers... | ASPIRIN, SOLIFENACIN | DrugsGivenReaction | CC BY-NC | 33955031 | 20,717,982 | 2021-05-05 |
What was the dosage of drug 'ASPIRIN'? | Medical students as junior adverse drug event managers facilitating reporting of ADRs.
The Junior Adverse Drug Event Manager (J-ADEM) team is a multifaceted intervention focusing on real-life education for medical students that has been shown to assist healthcare professionals in managing and reporting suspected advers... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 33955031 | 20,717,982 | 2021-05-05 |
What was the dosage of drug 'SOLIFENACIN'? | Medical students as junior adverse drug event managers facilitating reporting of ADRs.
The Junior Adverse Drug Event Manager (J-ADEM) team is a multifaceted intervention focusing on real-life education for medical students that has been shown to assist healthcare professionals in managing and reporting suspected advers... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 33955031 | 20,717,982 | 2021-05-05 |
What was the outcome of reaction 'Epistaxis'? | Medical students as junior adverse drug event managers facilitating reporting of ADRs.
The Junior Adverse Drug Event Manager (J-ADEM) team is a multifaceted intervention focusing on real-life education for medical students that has been shown to assist healthcare professionals in managing and reporting suspected advers... | Recovered | ReactionOutcome | CC BY-NC | 33955031 | 20,717,982 | 2021-05-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple-drug resistance'. | Responsive neurostimulation for focal motor status epilepticus.
No clear evidence-based treatment paradigm currently exists for refractory and super-refractory status epilepticus, which can result in significant mortality and morbidity. While patients are typically treated with antiepileptic drugs and anesthetics, neur... | BRIVARACETAM, CLOBAZAM, DEXAMETHASONE, DIAZEPAM, GABAPENTIN, IMMUNE GLOBULIN NOS, KETAMINE, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, METHYLPREDNISOLONE, MIDAZOLAM, OXCARBAZEPINE, PHENOBARBITAL, PHENYTOIN, PROPOFOL, PYRIDOXINE, RITUXIMAB, VALPROIC ACID | DrugsGivenReaction | CC BY | 33955717 | 20,123,852 | 2021-06 |
What was the administration route of drug 'IMMUNE GLOBULIN NOS'? | Responsive neurostimulation for focal motor status epilepticus.
No clear evidence-based treatment paradigm currently exists for refractory and super-refractory status epilepticus, which can result in significant mortality and morbidity. While patients are typically treated with antiepileptic drugs and anesthetics, neur... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33955717 | 20,123,852 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukaemia recurrent'. | Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report.
BACKGROUND
Acute myeloid leukemia (AML) is a disease with a significant amount of cytogenetic heterogeneity including mixed-lineage leukemia (MLL) gene rearrangements. Pediatric AML commonly has genetic rea... | CLOFARABINE, DECITABINE, GEMTUZUMAB OZOGAMICIN, THIOTEPA, TOPOTECAN HYDROCHLORIDE, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33957966 | 19,574,682 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report.
BACKGROUND
Acute myeloid leukemia (AML) is a disease with a significant amount of cytogenetic heterogeneity including mixed-lineage leukemia (MLL) gene rearrangements. Pediatric AML commonly has genetic rea... | BUSULFAN, CLOFARABINE, CYTARABINE, DAUNORUBICIN, DECITABINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, GEMTUZUMAB OZOGAMICIN, MITOXANTRONE HYDROCHLORIDE, THIOTEPA, TOPOTECAN HYDROCHLORIDE, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33957966 | 20,480,998 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report.
BACKGROUND
Acute myeloid leukemia (AML) is a disease with a significant amount of cytogenetic heterogeneity including mixed-lineage leukemia (MLL) gene rearrangements. Pediatric AML commonly has genetic rea... | BUSULFAN, CLOFARABINE, CYTARABINE, DAUNORUBICIN, DECITABINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, GEMTUZUMAB OZOGAMICIN, MITOXANTRONE HYDROCHLORIDE, THIOTEPA, TOPOTECAN HYDROCHLORIDE, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33957966 | 20,480,998 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report.
BACKGROUND
Acute myeloid leukemia (AML) is a disease with a significant amount of cytogenetic heterogeneity including mixed-lineage leukemia (MLL) gene rearrangements. Pediatric AML commonly has genetic rea... | BUSULFAN, CLOFARABINE, CYTARABINE, DAUNORUBICIN, DECITABINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, GEMTUZUMAB OZOGAMICIN, MITOXANTRONE HYDROCHLORIDE, THIOTEPA, TOPOTECAN HYDROCHLORIDE, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33957966 | 20,480,998 | 2021-05-07 |
What was the outcome of reaction 'Leukaemia recurrent'? | Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report.
BACKGROUND
Acute myeloid leukemia (AML) is a disease with a significant amount of cytogenetic heterogeneity including mixed-lineage leukemia (MLL) gene rearrangements. Pediatric AML commonly has genetic rea... | Fatal | ReactionOutcome | CC BY | 33957966 | 19,574,682 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Large-cell neuroendocrine tumor of the prostate: a case report and review of the literature.
BACKGROUND
Primitive neuroendocrine prostate neoplasms are rarely reported. This entity comprises carcinoïd tumors and poorly differentiated neuroendocrine tumors, mainly those of the small-cell type. Large-cell-type primitive ... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY | 33957979 | 19,372,324 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Large-cell neuroendocrine tumor of the prostate: a case report and review of the literature.
BACKGROUND
Primitive neuroendocrine prostate neoplasms are rarely reported. This entity comprises carcinoïd tumors and poorly differentiated neuroendocrine tumors, mainly those of the small-cell type. Large-cell-type primitive ... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY | 33957979 | 19,372,324 | 2021-05-07 |
What was the dosage of drug 'CARBOPLATIN'? | Large-cell neuroendocrine tumor of the prostate: a case report and review of the literature.
BACKGROUND
Primitive neuroendocrine prostate neoplasms are rarely reported. This entity comprises carcinoïd tumors and poorly differentiated neuroendocrine tumors, mainly those of the small-cell type. Large-cell-type primitive ... | DISCONTINUED AFTER SECOND CYCLE | DrugDosageText | CC BY | 33957979 | 19,426,653 | 2021-05-07 |
What was the dosage of drug 'ETOPOSIDE'? | Large-cell neuroendocrine tumor of the prostate: a case report and review of the literature.
BACKGROUND
Primitive neuroendocrine prostate neoplasms are rarely reported. This entity comprises carcinoïd tumors and poorly differentiated neuroendocrine tumors, mainly those of the small-cell type. Large-cell-type primitive ... | DISCONTINUED AFTER SECOND CYCLE | DrugDosageText | CC BY | 33957979 | 19,426,653 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report.
The emergence of epidermal growth factor receptor (EGFR) exon 20 p.C797S is one of the major resistance mechanisms for osimertinib. However, there are no standard of care for non-small cell ... | CATEQUENTINIB, CISPLATIN, OSIMERTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC | 33958875 | 19,492,543 | 2021 |
What was the dosage of drug 'CATEQUENTINIB'? | Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report.
The emergence of epidermal growth factor receptor (EGFR) exon 20 p.C797S is one of the major resistance mechanisms for osimertinib. However, there are no standard of care for non-small cell ... | 12MG/QD | DrugDosageText | CC BY-NC | 33958875 | 19,492,543 | 2021 |
What was the dosage of drug 'OSIMERTINIB'? | Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report.
The emergence of epidermal growth factor receptor (EGFR) exon 20 p.C797S is one of the major resistance mechanisms for osimertinib. However, there are no standard of care for non-small cell ... | 80 mg (milligrams). | DrugDosage | CC BY-NC | 33958875 | 19,492,543 | 2021 |
What was the dosage of drug 'PEMETREXED'? | Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report.
The emergence of epidermal growth factor receptor (EGFR) exon 20 p.C797S is one of the major resistance mechanisms for osimertinib. However, there are no standard of care for non-small cell ... | 800 mg (milligrams). | DrugDosage | CC BY-NC | 33958875 | 19,492,543 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.